aidsvilnius2009.com

Scientific Topics

1.    Clinical Science
1.1. New ARV therapy strategies
-    New Therapeutic Approaches and Treatment Strategies
-    Paediatric Treatment Strategies
-    Impact of opportunistic diseases on ARV treatment strategies
-    Clinical Trials of New Drugs/Pro-Drugs

1.2. Important aspects of current ARV therapies
-    Biological Markers for monitoring Disease Progression and Therapy
-    Resistance surveillance and testing in clinical practice
-    IDU ARV treatment failure and salvage therapy
-    Adherence
-    Survival after initiation of ART
-    Managing the side effects and Drug Interactions

1.3    Co-infections
-    HIV and tuberculosis
-    Viral hepatitis
-    HIV and STI interactions
-    DOTS

1.4    Drug abuse treatment
- oral substitution treatment
- heroin assisted treatment
- treating stimulant injectors (amphetamines, crack)
- drug free approaches
- integration of risk reduction approaches into addiction treatment

2.    Epidemiology and Surveillance

2.1.    Dynamics of the HIV-Epidemic
-    Determinants of Transmissibility, network analysis
-    other determinants (IDU dynamics, MTCT (mother-to-child-transmission) dynamics, migration, STI and sexual behaviour, imprisonment)
-    Substance use (alcohol, crack, IVDU) as risk factors for infectious diseases
2.2.    Molecular Epidemiology
2.3.    HIV-Prevalence/Incidence measurement
2.4.    Diagnostics & Monitoring Tools aimed at hard-to-reach populations
2.5.    Expanded HIV screening

3.    Social Science and Public Health
3.1 Drug Use, Sexuality and HIV-protection/risk behaviour
-    determinants and contexts of protection/risk behaviour
-    protection/risk behaviour in specific vulnerable groups (children, IDU, MSM, MSW, FSW, migrant populations, prisoners and ex-prisoners)
-    gender

3.2 Prevention: Concepts and Effects
-    risk reduction strategies vs. risk minimizing strategies
-    harm reduction, conditions for effective harm reduction in substance users, patient satisfaction with harm reduction approaches
-    prevention in hard to reach populations
-    gender and age
-    prevention in transforming societies/poor resource settings
-    cross border/EU-wide
-    early interventions
-    increasing coverage for effective harm reduction in substance users

3.3 Care and Support
-    support needs
-    access to care
-    gender, migration and age specific aspects
-    Care and support in transforming societies
-    Horizontal learning and intersectoral HIV case management
-    HIV and mental health

3.4 Societal Reactions on HIV/AIDS and Public Health Policies
-    PLWH and work; disability management
-    Stigma and exclusion vs. participation and inclusion
-    Legislation
-    Policy
-    Pricing and administration (affordability)